Cargando…
Mechanisims of asthma and allergic disease – 1094. Pre-clinical characterization of RP3133, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
Autores principales: | Routhu, Kasi Viswanath, Veeraraghavan, Sridhar, Merikapudi, Gayatri Swaroop, G, Babu, Viswanadha, Srikant, Vakkalanka, Swaroop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643267/ http://dx.doi.org/10.1186/1939-4551-6-S1-P90 |
Ejemplares similares
-
Simultaneous Quantification of Baricitinib and Methotrexate in Rat Plasma by LC-MS/MS: Application to a Pharmacokinetic Study
por: Veeraraghavan, Sridhar, et al.
Publicado: (2016) -
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
por: Huen, Auris, et al.
Publicado: (2020) -
Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis
por: Yalcin, Arzu Didem, et al.
Publicado: (2013) -
Mechanisims of asthma and allergic disease – 1074. Prebiotics in infants for prevention of allergic disease and hypersensitiivity
por: Sinn, John
Publicado: (2013) -
Mechanisims of asthma and allergic disease – 1070. Genetic mechanisms of immune imbalance in allergic inflamation
por: Ziyadullaev, Uktam
Publicado: (2013)